NYSE: NVS
Novartis Ag Stock

Overview

Forecast Earnings Dividend Ownership

NVS Price

$98.47

Fair Value Price

N/A

Market Cap

$227.58B

52 Week Low

$69.18

52 Week High

$99.84

P/E

19.23x

P/B

4.1x

P/S

4.5x

PEG

1.43x

Dividend Yield

13.66%

Revenue

$48.68B

Earnings

$11.73B

Gross Margin

70.4%

Operating Margin

29.53%

Profit Margin

24.1%

Debt to Equity

1.13

Operating Cash Flow

$14B

Beta

0.65

Next Earnings

N/A

Ex-Dividend

N/A

Next Dividend

N/A

Zen Score

Expand Score

High

Medium

Low

Industry average

Reasons for this score

NVS ($98.47) is trading below its intrinsic value of $311.96, according to Benjamin Graham's Formula from Chapter 14 of "The Intelligent Investor"

Valuation

NVS is good value based on its earnings relative to its share price (19.23x), compared to the US market average 31.52x)

Valuation

NVS is good value based on its earnings relative to its share price (19.23x), compared to the US Drug Manufacturers - General industry average (-5.79x)

Valuation

NVS News

Valuation

NVS price to earnings (PE)

For valuing profitable companies with steady earnings

Company

19.23x

Industry

-5.79x

Market

31.52x

NVS is good value based on its earnings relative to its share price (19.23x), compared to the US market average 31.52x)

Valuation

NVS is good value based on its earnings relative to its share price (19.23x), compared to the US Drug Manufacturers - General industry average (-5.79x)

Valuation

NVS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company

4.1x

Industry

9.92x

Market

56.65x

NVS is good value based on its book value relative to its share price (4.1x), compared to the US market average (56.65x)

Valuation

NVS is good value based on its book value relative to its share price (4.1x), compared to the US Drug Manufacturers - General industry average (9.92x)

Valuation

NVS price to earnings growth (PEG)

For valuing profitable companies with growth potential

NVS is poor value relative to its rate of earnings growth, measured by PEG ratio (1.43x)

Valuation

NVS's financial health

Profit margin

Revenue

$48.7B

Net Income

$11.7B

Profit Margin

24.1%

NVS's Earnings (EBIT) of $14.38B can safely cover interest payments on company debt ($29.33B)

Financials

NVS's profit margin has decreased (-3.3%) in the last year from (27.4%) to (24.1%)

Financials

Assets to liabilities

Assets

$118.4B

Liabilities

$62.8B

Debt to equity

0.53

NVS's short-term assets ($29.50B) exceed its short-term liabilities ($28.26B)

Financials

NVS's long-term liabilities ($34.56B) exceed its short-term assets ($29.50B)

Financials

NVS's debt has increased relative to shareholder equity (1.13), over the past 5 years ago (0.77)

Financials

NVS's debt to equity ratio (1.13) is considered high

Financials

Cash flow

Operating

$13.6B

Investing

-$2.2B

Financing

-$13.6B

NVS's operating cash flow ($13.63B) is sufficient to service the company's debt ($29.33B)

Financials

Novartis Ag Stock FAQ

What is Novartis Ag's quote symbol?

(NYSE: NVS) Novartis Ag trades on the NYSE under the ticker symbol NVS. Novartis Ag stock quotes can also be displayed as NYSE: NVS.

How much is Novartis Ag's stock price per share?

(NYSE: NVS) Novartis Ag stock price per share is $98.47 today (as of Jan 25, 2021).

What is the 52 week high and low for Novartis Ag (NYSE: NVS)?

(NYSE: NVS) Novartis Ag's 52-week high was $99.84, and its 52-week low was $69.18. It is currently -1.38% from its 52-week high and 42.34% from its 52-week low.

What is Novartis Ag's Market Cap?

(NYSE: NVS) Novartis Ag's market cap is $227.58B, as of Jan 27, 2021.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Novartis Ag's market cap is calculated by multiplying NVS's current stock price of $98.47 by NVS's total outstanding shares of 2,311,171,429.

How much is Novartis Ag stock worth today?

(NYSE: NVS) Novartis Ag currently has 2,311,171,429 outstanding shares. With Novartis Ag stock trading at $98.47 per share, the total value of Novartis Ag stock (market capitalization) is $227.58B.

Novartis Ag stock was originally listed at a price of $40.69 in Dec 31, 1997. If you had invested in Novartis Ag stock at $40.69, your return over the last 23 years would have been 142.03%, for an annualized return of 3.92%.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Zen Score

Reasons for this score

NVS News

Valuation

NVS price to earnings (PE)

For valuing profitable companies with steady earnings

NVS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

NVS price to earnings growth (PEG)

For valuing profitable companies with growth potential

NVS's financial health

Profit margin

Assets to liabilities

Cash flow

Novartis Ag Stock FAQ

(NYSE: NVS) Novartis Ag trades on the NYSE under the ticker symbol NVS. Novartis Ag stock quotes can also be displayed as NYSE: NVS.

(NYSE: NVS) Novartis Ag stock price per share is $98.47 today (as of Jan 25, 2021).

(NYSE: NVS) Novartis Ag's 52-week high was $99.84, and its 52-week low was $69.18. It is currently -1.38% from its 52-week high and 42.34% from its 52-week low.

Company

Stocks

Social